<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1538973079464292&amp;ev=PageView&amp;noscript=1">
MENU
Search

What are you looking for?

    Rep. Chris Smith Letter to NIH and HHS About COVID-19 and Lyme Disease

    by Admin at Global Lyme Alliance on April 18, 2020

    Blog Subscribe

    Facebook Twitter LinkedIn Copy to Clipboard
    <span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >Rep. Chris Smith Letter to NIH and HHS About COVID-19 and Lyme Disease</span>
    Representative Christopher H. Smith of New Jersey wrote a letter to the National Institute of Health's National Institute for Allergies and Infectious Disease Director Dr. Anthony Fauci and Department of Health and Human Services Secretary Alex Azar with the Health and Human Human Services (HHS), dated April 9, 2020. While Rep. Smith thanks Fauci and Azar for their tireless work on COVID-19, he brings important attention to his concern about " ... the countless individuals who live in this region who also suffer from Lyme Disease." Smith stresses his worry for how the virus may impact those with Lyme, stating "I remain deeply concerned about what impact COVID-19 and the Coronavirus outbreak will have on the countless Americans suffering from Lyme Disease and other related coinfections." Click here to read the entire letter.
    COVID-19 and Lyme Disease Resources from GLA: GLA POV:  Parallel Pandemics: COVID-19 and Lyme Disease Blog:  Q&A on COVID-19 and Lyme Disease with LLMD Blog: Personal  Patient Experience with COVID-19 and Lyme Disease Letter:  GLA CEO Addresses COVID-19 and GLA Community Letter: GLA Chairman on What We Can Learn from COVID-19 Response
    Global Lyme Alliance

    Admin at Global Lyme Alliance

    Global Lyme Alliance

    Email: info@globallymealliance.org

    We need some information
    GLA
    Global Lyme Alliance
    PO Box 25495
    New York, NY 10087-5495

    2023 © Copyright Global Lyme Alliance. All rights reserved.

    Disclaimer: The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. Global Lyme Alliance, Inc. makes no warranties of any kind regarding this Website, including as to the accuracy, completeness, currency or reliability of any information contained herein, and all such warranties are expressly disclaimed.